TY - JOUR
T1 - 21st century excitatory amino acid research
T2 - A Q & A with Jeff Watkins and Dick Evans
AU - Watkins, Jeffrey C
AU - Evans, Richard H
AU - Bayés, Àlex
AU - Booker, Sam
AU - Gibb, Alasdair
AU - Mabb, Angela
AU - Mayer, Mark
AU - Mellor, Jack R
AU - Molnar, Elek
AU - Niu, Li
AU - Ortega, Arturo
AU - Pankratov, Yuriy
AU - Ramos-Vincente, David
AU - Rodríguez-Campuzano, Ada
AU - Rodríguez-Moreno, Antonio
AU - Wang, Lu-Yang
AU - Wollmuth, Lonnie
AU - Wyllie, David
AU - Zhuo, Min
AU - Frenguelli, Bruno
N1 - Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2021/10/15
Y1 - 2021/10/15
N2 - In 1981 Jeff Watkins and Dick Evans wrote what was to become a seminal review on excitatory amino acids (EAAs) and their receptors (Watkins and Evans, 1981). Bringing together various lines of evidence dating back over several decades on: the distribution in the nervous system of putative amino acid neurotransmitters; enzymes involved in their production and metabolism; the uptake and release of amino acids; binding of EAAs to membranes; the pharmacological action of endogenous excitatory amino acids and their synthetic analogues, and notably the actions of antagonists for the excitations caused by both nerve stimulation and exogenous agonists, often using pharmacological tools developed by Jeff and his colleagues, they provided a compelling account for EAAs, especially l-glutamate, as a bona fide neurotransmitter in the nervous system. The rest, as they say, is history, but far from being consigned to history, EAA research is in rude health well into the 21st Century as this series of Special Issues of Neuropharmacology exemplifies. With EAAs and their receptors flourishing across a wide range of disciplines and clinical conditions, we enter into a dialogue with two of the most prominent and influential figures in the early days of EAA research: Jeff Watkins and Dick Evans.
AB - In 1981 Jeff Watkins and Dick Evans wrote what was to become a seminal review on excitatory amino acids (EAAs) and their receptors (Watkins and Evans, 1981). Bringing together various lines of evidence dating back over several decades on: the distribution in the nervous system of putative amino acid neurotransmitters; enzymes involved in their production and metabolism; the uptake and release of amino acids; binding of EAAs to membranes; the pharmacological action of endogenous excitatory amino acids and their synthetic analogues, and notably the actions of antagonists for the excitations caused by both nerve stimulation and exogenous agonists, often using pharmacological tools developed by Jeff and his colleagues, they provided a compelling account for EAAs, especially l-glutamate, as a bona fide neurotransmitter in the nervous system. The rest, as they say, is history, but far from being consigned to history, EAA research is in rude health well into the 21st Century as this series of Special Issues of Neuropharmacology exemplifies. With EAAs and their receptors flourishing across a wide range of disciplines and clinical conditions, we enter into a dialogue with two of the most prominent and influential figures in the early days of EAA research: Jeff Watkins and Dick Evans.
KW - glutamate receptor
KW - pharmacology
KW - drug discovery
UR - https://www.sciencedirect.com/science/article/pii/S0028390821002987?via%3Dihub
U2 - 10.1016/j.neuropharm.2021.108743
DO - 10.1016/j.neuropharm.2021.108743
M3 - Article (Academic Journal)
C2 - 34363811
SN - 0028-3908
VL - 198
JO - Neuropharmacology
JF - Neuropharmacology
M1 - 108743
ER -